PHA-30055 - Module Specification
School of Pharmacy and Bioengineering
Faculty of Medicine & Health Sciences

Programme/Approved Electives for 2024/25

Available as a Free Standing Elective

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2024/25

One in two British people will develop cancer in their lifetime with recent statistics pointing to the fact that more than four million people will be living with a cancer diagnosis by 2030. By studying this module, students will learn about molecular oncology, current therapeutic strategies, and the wider impact of a cancer diagnosis and treatments on society. They will also explore how new cancer treatment strategies are designed and tested and how we can personalise cancer treatment for oncological patients.

The module will expose final year students to basic principles of neoplastic transformation, the hallmarks of cancer, and how this knowledge can be used for the development of a targeted therapeutic approach in oncology.

Intended Learning Outcomes

Demonstrate an in depth understanding of the hallmarks of cancer, functional capabilities acquired by normal cells during neoplastic transformation.: 1
Comprehend the molecular pathways that contribute to the neoplastic transformation and the opportunities for pharmacological treatment of cancer using targeted therapeutics.: 1
Critically evaluate the advantages and disadvantages of these pathways compared to each and to conventional chemotherapy.: 1
Demonstrate an in depth knowledge of the mechanism of action of drugs used for cancer patients.: 1

Study hours

Lectures and presentation: 18 hours
Independent Study hours:
Pre-reading: 18 hours
Researching and studying: 74 hours
Drafting assessment: 40 hours

School Rules

None

Description of Module Assessment